APA (7th ed.) Citation

Smith, E., Al-Abadi, E., Armon, K., Bailey, K., Ciurtin, C., Davidson, J., . . . Sridhar, A. (2019). Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. Lupus, 28(5), 613. https://doi.org/10.1177/0961203319836712

Chicago Style (17th ed.) Citation

Smith, EMD, et al. "Outcomes Following Mycophenolate Mofetil Versus Cyclophosphamide Induction Treatment for Proliferative Juvenile-onset Lupus Nephritis." Lupus 28, no. 5 (2019): 613. https://doi.org/10.1177/0961203319836712.

MLA (9th ed.) Citation

Smith, EMD, et al. "Outcomes Following Mycophenolate Mofetil Versus Cyclophosphamide Induction Treatment for Proliferative Juvenile-onset Lupus Nephritis." Lupus, vol. 28, no. 5, 2019, p. 613, https://doi.org/10.1177/0961203319836712.